Bevacizumab/carboplatin/vinorelbineLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1917卷 / 1期

关键词：

D O I：

10.1007/s40278-022-19999-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：128 / 128

相关论文

共 50 条

[41] Carboplatin/paclitaxelLack of efficacy: case report
Reactions Weekly, 2022, 1914 (1) : 146 - 146
[42] Carboplatin/paclitaxelLack of efficacy: case report
Reactions Weekly, 2020, 1816 (1) : 95 - 95
[43] Carboplatin/etoposideLack of efficacy: case report
Reactions Weekly, 2025, 2047 (1) : 103 - 103
[44] Carboplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2023, 1942 (1) : 80 - 80
[45] Carboplatin/paclitaxelLack of efficacy: case report
Reactions Weekly, 2023, 1962 (1) : 116 - 116
[46] Carboplatin/paclitaxelLack of efficacy: case report
Reactions Weekly, 2021, 1853 (1) : 111 - 111
[47] Carboplatin/paclitaxelLack of efficacy: case report
Reactions Weekly, 2022, 1891 (1) : 85 - 85
[48] Carboplatin/vincristineLack of efficacy: case report
Reactions Weekly, 2022, 1904 (1) : 135 - 135
[49] Carboplatin/etoposideLack of efficacy: case report
Reactions Weekly, 2022, 1931 (1) : 166 - 166
[50] Carboplatin/paclitaxelLack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 146 - 146

← 1 2 3 4 5 →